Michael R. Gold

Michael R. Gold publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael R. Gold sits on this spectrum.

Michael R. Gold D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Gold sits on this spectrum.

Overview

Best Publications

• Subclinical Atrial Fibrillation and the Risk of Stroke

  Jeff S. Healey;Stuart J. Connolly;Michael R. Gold;Carsten W. Israel

  2271
  Citations

• Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms

  Cecilia Linde;William T. Abraham;Michael R. Gold;Martin St. John Sutton

  1682
  Citations

• Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

  Wojciech Zareba;Helmut Klein;Iwona Cygankiewicz;W. Jackson Hall

  940
  Citations

• 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

  Fred M. Kusumoto;Mark H. Schoenfeld;Coletta Barrett;James R. Edgerton

  904
  Citations

• Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events

  Michela Brambatti;Stuart J. Connolly;Michael R. Gold;Carlos A. Morillo

  738
  Citations

• Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death

  A E Buxton;K L Lee;L DiCarlo;M R Gold

  686
  Citations

• An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.

  John G. Cleland;William T. Abraham;Cecilia Linde;Michael R. Gold

  595
  Citations

• Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

  Raul Weiss;Bradley P. Knight;Michael R. Gold;Angel R. Leon

  558
  Citations

• Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchronization Therapy

  Kenneth A. Ellenbogen;Michael R. Gold;Timothy E. Meyer;Ignacio Fernández Lozano

  545
  Citations

• Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

  Isabelle C. Van Gelder;Jeff S. Healey;Harry J. G. M. Crijns;Jia Wang

  536
  Citations

• Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry

  Martin C. Burke;Michael R. Gold;Bradley P. Knight;Craig S. Barr

  527
  Citations

• Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. Lessons from the MUSTT study

  Alfred E. Buxton;Kerry L. Lee;Gail E. Hafley;Luis A. Pires

  491
  Citations

• Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

  Claude Daubert;Michael R. Gold;William T. Abraham;Stefano Ghio

  482
  Citations

• Electrical Storm Presages Nonsudden Death The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial

  Derek V. Exner;Sergio L. Pinski;D. George Wyse;Ellen Graham Renfroe

  459
  Citations

• The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers and Arrhythmia Monitors: Facilities and Patient Management This document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS)

  George H. Crossley;Jeanne E. Poole;Marc A. Rozner;Samuel J. Asirvatham

  408
  Citations

• Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.

  Michael R. Gold;Christophe Thébault;Cecilia Linde;William T. Abraham

  378
  Citations

• The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy

  Michael R. Gold;Ulrika Birgersdotter-Green;Jagmeet P. Singh;Kenneth A. Ellenbogen

  368
  Citations

• A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification

  Michael R Gold;Daniel M Bloomfield;Kelley P Anderson;Nabil E El-Sherif

  359
  Citations

• Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study.

  Michael R. Gold;Zenaida Feliciano;Stephen S. Gottlieb;Michael L. Fisher

  351
  Citations

• 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay

  Fred M. Kusumoto;Mark H. Schoenfeld;Coletta Barrett;James R. Edgerton

  122
  Citations